1. Presented by :-
Md. Hamidul Kowsar
Dept. of Pharmacy
State University of Bangladesh
Aerosol Dosage form
2. Word Origin :
the Greek word “αήρ” (aeros) means Air and the English word
“sol”, of Latin origin, which means solution.
Definition :
Pharmaceutical aerosols are pressurized dosage forms
containing one or more active ingredients
intended for administration orally or nasally as fine solid
particles or liquid mists through the pulmonary airways, nasal
passages or oral cavity.
Example : nebulizers, DPIs
Aerosol Dosage form
4. An aerosol formulation consists of the product
concentrate, the propellant, Container, Valve .
The product concentrate is the active ingredient
such as antioxidants, surface-active agents,
solvents, and efficacious product
A propellant is a chemical with a vapor pressure
greater than atmospheric pressure at 40°C
(105°F). Example : chlorofluorocarbons,
hydrocarbons,hydrofluorocarbons etc.
Aerosol Dosage form
5. Solution system / Two phase system
Water based system / Two components or Three
components system
Suspension / Dispersion system
Foam system / Emulsion system
Aqueous stable foams
Non-Aqueous stable foams
Quick Breaking foams
Thermal foams
Intra nasal aerosols
Compressed gas systems
Types of aerosol
system
Aerosol Dosage form
6. Aerosols are easy and convenient to apply
The onset of action is faster
The dispersion of medicament is very good.
It also can avoid the first pass metabolism.
Metered valve can release the contents in controlled
and uniformly.
Sterility can be for sterile product
For Inhalation purpose a fine mist of the drug is
produced.
Irritation can be reduced
Advantages
Aerosol Dosage form
7. Aerosols are cost effective .
Disposal empty aerosol containers are difficult.
Due to volatility of the propellant can irritate the
injured skin.
Aerosol packs must away from temperature and fire.
Sometimes propellants may cause toxic reations.
Disadvantage
Aerosol Dosage form
8. Physical stability of aerosol dispersion can be
increased by :
Control of moisture content. (<300ppm)
Reduction of initial particle size to less than 5 um.
Adjustment of density of propellant and suspensoid so
that they are equalized.
Use of dispersing agent
Use of derivatives of active ingredients with minimum
solubility in propellant system.
9. Physical stability of a dispersed system depends on rate
of agglomeration of the suspensoid.
Agglomeration is acceleration at elevated temp. and it is
also affected by particle size of drug (1-5u, never >50u).
Isopropyl myristate and mineral oil are used to reduce
agglomeration .
Surfactants of HLB value less than 10 are utilized for
aerosol dispersions
Surfactants are effective in a concentration of 0.01 to 1
%.
Aerosol Dosage form